D-EYE Srl, a pioneering developer of smartphone-based retinal screening, announced today the introduction of its version 2.0 App for iPhones. The updated App, available as a free download from the Apple Store, enhances functionality, allowing healthcare practitioners to more easily screen for eye health issues.
New features include auto focus calibration for myopic, hyperopic, and emmetropic eyes, saving time when conducting each retinal exam. An Image Mask feature is also part of the new App, allowing users to highlight the posterior pole in real time. Image editing features have also been expanded to include contrast, brightness, RGB, Gamma, and saturation. And, for the iPhone 6, 6S, 6+, 6S+, users can now easily log on to the D-EYE app via the new “Touch ID” feature.
“Customer satisfaction and continual enhancement are top priorities for D-EYE, especially considering how quickly the technological landscape advances. Our project development team has listened to our customers and quickly responded,” said D-EYE CEO Richard Sill. “Ease of use and image capturing and editing capabilities were top concerns amongst healthcare practitioners using our product and I know they will be pleased with this latest update,” he added.
The patent pending D-EYE lens is the invention of Italian Ophthalmologist Andrea Russo, who saw the opportunity to use the light source and camera of smartphones to perform direct ophthalmoscopy when examining patients. D-EYE is currently under evaluation/being used by Ophthalmologists, Optometrists, Neurologists, Pediatricians, Endocrinologists, Hospitalists, Primary Care and Emergency Medical Physicians.
D-EYE and the D-EYE App can be used with the iPhone 5, 5S, SE, 6, 6S, 6+, and 6S+.
For additional information, please visit http://d-eyecare.com/
*Note: Version 2.0 is a separate app from 1.0. No data can be transferred from 1.0 to 2.0. Before deleting 1.0 from the smartphone, images (no specific patient information) should be moved to the camera roll for safe keeping.
Founded in 2014, with offices in Padova, Italy and Pasadena, CA, D-EYE Srl offers a “digital eye” into the state of the human body. The company designs and manufactures mobile sensing and examination devices, along with companion applications, that make possible mass health screenings and data collection to improve access to vital health examination services. D-EYE also develops and operates cloud-based Platform-as-a-Service (PaaS) systems that enable telehealth applications, and aggregate and analyze health-screening data to provide insight into individual conditions as well as trends across patient populations.
The company’s first product, developed in part with a grant from the Fondazione Cottino and with support from the University of Brescia (Italy), the revolutionary D-EYE Smartphone-based Retinal Imaging System focuses on eye care; subsequent mobile-health products and services will target screening and evaluation of other medical conditions and pathologies. For more information, please visit www.d-eyecare.com.